CONCLUSIONS
cancer, T2D, diabetes
CANCER, DIABETES
Despite a number of patients being interested in participating, only three were enrolled in this study. This study was not feasible due to the cost, time, and personnel needed to screen participants with a POC HbA1c test. This suggests a willingness and interest for patients to participate, but reliance on POC HbA1c testing is inefficient. While findings were promising, we are unable to make any meaningful conclusions regarding the HbA1c levels, diabetes self‐management, or participant acceptability of the study. However, routine HbA1c screening for all patients newly diagnosed with cancer could identify patients in whom T2D management is indicated. With refinements to this intervention, there remains potential for improving access to T2D care as well as detection and management of undiagnosed T2D for those newly diagnosed with cancer with opportunities for early and safe intervention through nursing led point‐of‐care T2D interventions.